CRB Monitor Securities Database Updates
During the week of September 25 - October 1, 2023, CRB Monitor’s research team made several updates to securities’ information and added source documents & relevant news articles to the CRB Monitor database.
Summary of the updates for the Week of September 25 - October 1, 2023:
|
Tier |
Total # |
Active / Inactive / Pre-IPO |
Added |
Removed |
Net Change |
|
Tier 1A |
149 |
124 / 23 / 2 |
+0 | -0 | +0 |
|
Tier 1B |
722 |
568 / 152 / 2 |
+0 | -0 | +0 |
|
Tier 2 |
341 |
316 / 20 / 5 |
+0 | -1 | -1 |
|
Tier 3 |
501 |
473 / 27 / 1 |
+1 | -0 | +1 |
|
Total Issuances |
1,713 |
1,481 / 222 / 10 |
+1 | -1 | +0 |
|
Total Issuers (w/o Pre-IPOs) |
1,291 |
- |
+1 | -1 | +0 |
|
Total Issuers (w/ Pre-IPOs) |
1,301 |
- |
+1 | -1 | +0 |
- Removed 1 Tier 2 Security:
- -1 = Discarded Business Record from Database: (“Canna Corporation”)
- Rationale = Canna Corporation is a US-based cryptocurrency company which entered into agreements to acquire companies operating in the hemp/CBD products sector. However, The company's security has been revoked/delisted and it no longer trades (announced by the SEC on September 28, 2023). As a result, the company is now private. This is a business without any connection to (1) a cannabis license/"plant-touching" operation, (2) a Tier 1 CRB, and/or (3) a publicly-traded CRB. Therefore, this business no longer qualifies for inclusion.
- -1 = Discarded Business Record from Database: (“Canna Corporation”)
- Added 1 Tier 3 Security:
- +1 = New CRB: (“Pathway Health Corp.”)
- +1 = New CRB: (“Pathway Health Corp.”)
All newly-identified CRBs during the week:
|
Company Name |
Tier |
Pure-Play | Sector |
Description |
| 3 | No | Professional Services | Pathway Health Corp. is a Canada-based company, whose principal business is the operation of medical clinics that offer multidisciplinary therapies to patients that suffer from chronic pain. The clinical services are delivered in inter-disciplinary pain clinics operated by it and through virtual care by physicians and other health care providers, who are trained in managing chronic pain through assessment and multi-modality treatments that include minimally invasive approaches, intravenous therapies, allied health methods and the prescription of medical cannabis, which is supplied to the patient directly by licensed producers. Pathway has established itself as the leading partner with national and regional pharmacy companies for the delivery of medical cannabis services to their customers. Pathway is working with several pharmacy companies on the development of Cannabis Health Products (CHPs) for OTC product distribution through retail pharmacy locations across Canada. |